Cutaneous Rosai-Dorfman disease accompanied by Langerhans cell hyperplasia responsive to combined treatment.
- Author:
Jin WEI
1
;
Yu ZHANG
2
;
Jiang JIN
1
;
Jianzhong ZHANG
3
,
4
Author Information
1. Department of Dermatology, Peking University People's Hospital, Beijing 100044, China.
2. Department of Dermatology, China Aerospace 731 Hospital, Beijing 100074, China.
3. Department of Dermatology, Peking University People's Hospital, Beijing 100044, China. Email: rmzjz@
4. com.
- Publication Type:Case Reports
- MeSH:
Adrenal Cortex Hormones;
therapeutic use;
Adult;
Antitubercular Agents;
therapeutic use;
Female;
Histamine Antagonists;
therapeutic use;
Histiocytosis, Sinus;
diagnosis;
drug therapy;
Humans;
Hyperplasia;
diagnosis;
drug therapy;
Langerhans Cells;
drug effects;
pathology;
Prednisone;
therapeutic use;
Young Adult
- From:
Chinese Medical Journal
2014;127(17):3200-3200
- CountryChina
- Language:English
